ASPHO 2021 - American Society of Pediatric Hematology / Oncology Annual Meeting (Virtual Meeting)
Apr 20 - Apr 23, 2021 | PortlandORUS
LARVOL is not affiliated with American Society of Pediatric Hematology / Oncology Annual Meeting (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 21 abstracts linked to Trials
2008 - [VIRTUAL] AZACITIDINE AS EPIGENETIC PRIMING FOR CHEMOTHERAPY IS SAFE IN INFANTS WITH KMT2A-REARRANGED ALL
93 - [VIRTUAL] IBRUTINIB+RICE/RVICI FOR R/R MATURE B-NHL IN CHILDREN/YOUNG ADULTS: SPARKLE TRIAL INTERIM ANALYSIS
103 - [VIRTUAL] A PHASE 1 STUDY OF TALIMOGENE LAHERPAREPVEC (T-VEC) IN PEDIATRIC PATIENTS WITH ADVANCED SOLID TUMORS
181 - [VIRTUAL] ZUMA-4 PHASE 1 LONG-TERM RESULTS: KTE-X19 CAR T-CELL THERAPY IN CHILDREN/ADOLESCENTS WITH R/R B-ALL
2 - [VIRTUAL] First-in-human HA-1 targeting TCR memory T cell immunotherapy for pediatric patients with relapsed hematologic malignancies post allogeneic hematopoietic cell transplantation
4 - [VIRTUAL] Hematopoietic Toxicities and Coagulopathy Following CD22 CAR T-cells
2002 - [VIRTUAL] UPDATED RESULTS FROM THE HGB-206 GROUP C STUDY OF LENTIGLOBIN FOR SICKLE CELL DISEASE GENE THERAPY
3 - [VIRTUAL] LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
25 - [VIRTUAL] SAFETY AND EFFICACY OF DEFERIPRONE VS DEFEROXAMINE FOR TRANSFUSION-DEPENDENT ANEMIAS
26 - [VIRTUAL] BETI-CEL GENE THERAPY OUTCOMES IN PEDIATRIC PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA
100 - [VIRTUAL] POST-HSCT OUTCOMES AFTER EMAPALUMAB TREATMENT IN PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
101 - [VIRTUAL] MYPART RARE TUMOR NETWORK: EARLY RESULTS AND INTERIM ANALYSIS OF CHORDOMA AND ACC PATIENT COHORTS
122 - [VIRTUAL] VIROIMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMAS
219 - [VIRTUAL] REAL-WORLD EXPERIENCE OF PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE TREATED WITH OXBRYTA®
266 - [VIRTUAL] CROSSING OUR T'S: AN UNUSUAL PRESENTATION OF INFANTILE T-CELL LEUKEMIA